Financhill
Back

Theriva Biologics Stock Predictions

Theriva Biologics Stock Forecast

  • Is Theriva Biologics Stock Undervalued?
    The current Theriva Biologics [TOVX] share price is $1.76. The Score for TOVX is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
  • TOVX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Theriva Biologics Stock Go Up Next Year?

Data Unavailable

Theriva Biologics Stock Rating

Data Unavailable

Theriva Biologics Stock Price History

Is TOVX stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TOVX is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NYAM
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
therivabio.com

52-Week Data

52-Week High:
17.11
52-Week Low:
1.14

Prediction Charts

Market Cap:
4.9M
Price in USD:
1.76
Volume:
6.8M
Beta:
-65.62

Technical Analysis

SMA50:
1.44
SMA100:
2.44
SMA200:
5.52
52-Wk Change:
-83.91%

Stock Predictions

  • Is Theriva Biologics stock public?
    Yes, Theriva Biologics is a publicly traded company.
  • What is the Theriva Biologics stock quote today?
    The Theriva Biologics stock price is 1.76 USD today.
  • How to buy Theriva Biologics stock online?
    You can buy Theriva Biologics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-5 1.29 1.29 1.33 1.23
Dec-6 1.27 1.27 1.31 1.25
Dec-9 1.27 1.30 1.33 1.26
Dec-10 1.29 1.29 1.34 1.28
Dec-11 1.23 1.14 1.28 1.14
Dec-12 1.14 1.19 1.20 1.14
Dec-13 1.17 1.18 1.21 1.14
Dec-16 1.18 1.17 1.21 1.16
Dec-17 1.20 1.19 1.20 1.15
Dec-18 1.15 1.17 1.21 1.15
Dec-19 1.19 1.15 1.19 1.14
Dec-20 1.16 1.14 1.19 1.14
Dec-23 1.17 1.30 1.33 1.15
Dec-24 1.55 1.76 2.08 1.47

Theriva Biologics Earnings

Data Unavailable

Theriva Biologics Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.00 per share, and an increase next year of $22.60 per share.

* Theriva Biologics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.